Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic ...

Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic ...

An article published in the journal Gastroenterology & Hepatology highlights recent updates to eosinophilic gastrointestinal disease nomenclature, as well as updates related to diagnosis, pathogenesis ...

An international team has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has ...

Dr. Michael Wechsler, Professor of Medicine and Director of The Asthma Institute at National Jewish Health, and International Coordinating Investigator of the MANDARA trial said: “This approval is ...

The good news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the number of eosinophils found in the blood and digestive tract tissues of ...

Among pediatric patients with eosinophilic esophagitis, around a quarter had joint hypermobility, according to results ...

Eosinophilic lung diseases encompass a spectrum of disorders characterised by the accumulation of eosinophils within pulmonary tissues and airspaces. Pathogenesis is driven by dysregulated type 2 ...

Share on Pinterest The condition eosinophilic esophagitis can make it difficult for children to eat. Westend61/Getty Images Researchers have published new research about eosinophilic esophagitis (EoE) ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the MANDARA Phase III trial showed AstraZeneca’s FASENRA (benralizumab) met the primary endpoint of the trial and demonstrated ...

Please provide your email address to receive an email when new articles are posted on . Patients with food allergies were 15.8 times more likely to develop eosinophilic esophagitis. The prevalence of ...